Resultado de búsqueda
9 de may. de 2024 · May 9, 2024 9:30am. David Tennant stars in Disney+ series 'Rivals' Disney. Disney + is building buzz for its Jilly Cooper adaptation Rivals by teasing first-look images of the eight-part series ...
12 de may. de 2024 · Asked about the status of the Prime Video series, Tennant reaffirmed Gaiman's update from last month that a January 2025 filming start was still on track. When Visage joked that the final season ...
8 de may. de 2024 · Actor David Tennant—best known for his work on Doctor Who—had LGBTQ+ fans cheering after he criticized transphobes when asked by a transgender fan about his personal views on sexuality and gender.. Speaking at the Proud Nerd: Angels, Demons and Doctors convention in Germany on May 5, Tennant addressed the fan’s question, and affirmed his steadfast commitment to supporting the LGBTQ+ ...
10 de may. de 2024 · David Tennant (‘ Doctor Who ’, ‘Good Omens’) features as Lord Tony Baddingham, controller of Corinium Television and Rupert’s single-mindedly ambitious and egotistical adversary. Aidan Turner (‘Poldark’, ‘The Suspect’) is journalist and TV presenter Declan O’Hara, who becomes caught in the crossfire of the long-simmering ...
14 de may. de 2024 · Fans of Jilly Cooper have been treated to a first look at David Tennant and Aidan Turner in the upcoming adaptation of Rivals on Disney+. Spanning eight-episodes, the new series is based on the ...
13 de may. de 2024 · Karina Smitt May 13, 2024. One of the most well-known actors to play Doctor Who in Britain, David Tennant, has a message on transgenderism and expresses his frustration with the “weaponization” of transgender rights. His criticism is directed at individuals who oppose transgenderism rather than the transgender people who are trying to ...
Hace 1 día · 2 analysts have issued twelve-month price targets for Tennant's shares. Their TNC share price targets range from $100.00 to $112.00. On average, they anticipate the company's share price to reach $106.00 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price.
